Holen Sie sich die Stockscreener-App
20.55
13.22%
-3.13
Handel nachbörslich:
20.54
-0.01
-0.05%
Schlusskurs vom Vortag:
$23.68
Offen:
$21.95
24-Stunden-Volumen:
2.68M
Relative Volume:
2.64
Marktkapitalisierung:
$2.10B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-804.34M
KGV:
-2.1838
EPS:
-9.41
Netto-Cashflow:
$-531.06M
1W Leistung:
-27.62%
1M Leistung:
-35.90%
6M Leistung:
-55.95%
1J Leistung:
-60.69%
1-Tages-Spanne:
$20.41
$22.24
1-Wochen-Bereich:
$20.41
$28.50
52-Wochen-Spanne:
$20.41
$55.72
Biohaven Ltd Stock (BHVN) Company Profile
Firmenname
Biohaven Ltd
Sektor
Branche
Telefon
203-404-0410
Adresse
215 CHURCH STREET, NEW HAVEN, CT
Vergleichen Sie BHVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
20.55 | 2.10B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-09-16 | Eingeleitet | Jefferies | Buy |
| 2024-09-04 | Eingeleitet | Bernstein | Outperform |
| 2024-07-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2023-12-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-01-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-04 | Eingeleitet | JP Morgan | Overweight |
| 2022-12-02 | Eingeleitet | BTIG Research | Buy |
| 2022-10-26 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-08-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-05-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Herabstufung | UBS | Buy → Neutral |
| 2021-08-03 | Bestätigt | Canaccord Genuity | Buy |
| 2021-03-11 | Eingeleitet | UBS | Buy |
| 2020-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-17 | Eingeleitet | Cowen | Outperform |
| 2020-02-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2019-11-22 | Eingeleitet | Wedbush | Outperform |
| 2019-06-25 | Bestätigt | Canaccord Genuity | Buy |
| 2019-05-06 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Bestätigt | Needham | Buy |
| 2018-07-03 | Bestätigt | Needham | Buy |
| 2018-07-02 | Bestätigt | Needham | Buy |
| 2018-04-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Bestätigt | Canaccord Genuity | Buy |
| 2017-12-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-03 | Bestätigt | Needham | Buy |
Alle ansehen
Biohaven Ltd Aktie (BHVN) Neueste Nachrichten
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March - The Motley Fool
Corebridge Financial Inc. Acquires 2,552 Shares of Biohaven Ltd. (NYSE:BHVN) - Defense World
KLP Kapitalforvaltning AS Acquires Shares of 16,100 Biohaven Ltd. (NYSE:BHVN) - Defense World
Raymond James Financial Inc. Purchases Shares of 37,033 Biohaven Ltd. (NYSE:BHVN) - Defense World
American Century Companies boosts stake in Biohaven, ETF Daily News says - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven LtdBHVN - PR Newswire
Biohaven Ltd. Shares Tumble Amid Market Reassessment - TipRanks
Biohaven Ltd. (NYSE:BHVN) Shares Bought by American Century Companies Inc. - Defense World
Teacher Retirement System of Texas Raises Stake in Biohaven Ltd. (NYSE:BHVN) - Defense World
(BHVN) Proactive Strategies - Stock Traders Daily
Biohaven stock hits 52-week low at $26.7 amid market challenges By Investing.com - Investing.com South Africa
Biohaven stock hits 52-week low at $26.7 amid market challenges - Investing.com India
Biohaven (BHVN) Stock Price, News & Analysis - MarketBeat
Emerald Advisers LLC Acquires New Holdings in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Amundi - Defense World
Major Player in the Multiple System Atrophy (MSA) Market - openPR
Multiple System Atrophy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Ionis Pharma - Barchart
Multiple System Atrophy Market to Reach New Heights in Growth - openPR
Immunovant data positive for Biohaven, says Deutsche Bank - TipRanks
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
How To Trade (BHVN) - Stock Traders Daily
Biohaven’s 47% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com Australia
SEC Form DEF 14A filed by Biohaven Ltd. - Quantisnow
Spinocerebellar Ataxias Pipeline 2025: Therapies, MOA - openPR
Charles Schwab Investment Management Inc. Increases Stock Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven Ltd. Being Investigated on Behalf of Biohaven Ltd. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
US Bancorp DE Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Shareholders to Connect - Markets Insider
Biohaven Ltd. Under Investigation: Levi & Korsinsky Probes Potential Securities Violations - Apna Kal
Investors who lost money on Biohaven Ltd. should contact Levi & Korsinsky about an ongoing investigationBHVN - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect - Markets Insider
Biohaven Ltd. (NYSE:BHVN) Shares Bought by Bank of New York Mellon Corp - Defense World
Unpartnered Obesity Assets Are Becoming Slim Pickings For Pharma - Citeline News & Insights
Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Stockholders to Inquire about Securities Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Biohaven Ltd. (NYSE:BHVN) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Biohaven Ltd. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Biohaven Ltd. (BHVN) - ACCESS Newswire
Biohaven Ltd. (BHVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
ATTENTION Biohaven Ltd. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Positive Outlook for Biohaven Ltd. Amid Promising Developments and FDA Priority Review - TipRanks
Independent Director of Biohaven John Childs Buys More Stock - Simply Wall St
Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025 - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Biohaven Ltd. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsBHVN - ACCESS Newswire
Morgan Stanley Lowers Biohaven (NYSE:BHVN) Price Target to $63.00 - Defense World
How to Take Advantage of moves in (BHVN) - Stock Traders Daily
Empowering women in STEM: Navigating CMC regulatory affairs -March 08, 2025 at 04:31 am EST - Marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Investors to Inquire about Securities Investigation - markets.businessinsider.com
Biohaven price target lowered to $63 from $69 at Morgan Stanley - Yahoo Finance
Piper Sandler maintains Biohaven stock with $76 target - Investing.com India
Finanzdaten der Biohaven Ltd-Aktie (BHVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.23%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):